![Rekha Hemrajani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 145 892 $ al 30/09/2026
Rekha Hemrajani is the founder of Ravinia Consulting, Inc. Current jobs include Independent Non-Executive Director at MaxCyte, Inc. since 2021, Independent Director at BioAge Labs, Inc. since 2021, Director at ALX Oncology, Inc. since 2020, Director & Partner at Hemmo Pharmaceuticals Pvt Ltd., Independent Non-Executive Director at ALX Oncology Holdings, Inc. since 2020, Director & Partner at Hemmo Pharma LLP, and Independent Director at LB Pharmaceuticals, Inc. starting 2025.
Former jobs include President, Chief Executive Officer & Director at Aravive, Inc. in 2020, Chief Executive Officer & Director at Jiya Acquisition Corp.
from 2020 to 2022, Independent Director at Adverum Biotechnologies, Inc. from 2019 to 2021, Vice President at Lehman Brothers, Inc., VP & Head-Licensing, Mergers & Acquisitions at Onyx Pharmaceuticals, Inc. from 2012 to 2013, Vice President-Business Development at Exelixis, Inc. from 2003 to 2011, CFO, SVP-Business & Financial Operations at Sagimet Biosciences, Inc. from 2015 to 2016, Chief Operating Officer at Rapt Therapeutics, Inc. from 2016 to 2019, and Chief Operating & Financial Officer at Arcus Biosciences, Inc. in 2019.
Education includes undergraduate studies at the University of Michigan and an MBA from Kellogg School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MAXCYTE, INC. 0,07 % | 17/06/2026 | 70.314 ( 0,07 % ) | 78 752 $ | 30/09/2026 |
| 31/03/2026 | 33.000 ( 0,02 % ) | 45 870 $ | 30/09/2026 | |
BIOAGE LABS, INC. 0,01 % | 10/06/2026 | 3.000 ( 0,01 % ) | 21 270 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Director/Miembro de la Junta | 01/04/2020 |
| MAXCYTE, INC. | Director/Miembro de la Junta | 15/06/2021 |
| BIOAGE LABS, INC. | Director/Miembro de la Junta | 19/08/2021 |
| LB PHARMACEUTICALS INC | Director/Miembro de la Junta | 10/09/2025 |
ALX Oncology, Inc.
 ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company which develops therapies for cancers | Director/Miembro de la Junta | 04/05/2020 |
Hemmo Pharma LLP | Director/Miembro de la Junta | - |
Hemmo Pharmaceuticals Pvt Ltd.
 Hemmo Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures peptide APIs | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| JIYA ACQUISITION CORP. | Director Ejecutivo | 01/11/2022 |
| ADVERUM BIOTECHNOLOGIES, INC. | Director/Miembro de la Junta | 12/05/2021 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 19 |
|---|---|
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
MaxCyte, Inc.
 MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sagimet Biosciences, Inc.
 Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops gene therapies | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rapt Therapeutics, Inc.
 Rapt Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oral small molecule therapies for patients | Health Technology |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
LB Pharmaceuticals, Inc.
 LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and neuropsychiatric diseases | Health Technology |
BioAge Labs, Inc.
 BioAge Labs, Inc. BiotechnologyHealth Technology Develops therapies obesity for metabolic diseases | Health Technology |
Aravive, Inc.
 Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies | Health Technology |
ALX Oncology, Inc.
ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company which develops therapies for cancers | Health Technology |
Hemmo Pharmaceuticals Pvt Ltd.
Hemmo Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures peptide APIs | Health Technology |
ALX Oncology Holdings, Inc.
 ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
Jiya Acquisition Corp.
 Jiya Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Hemmo Pharma LLP | |
Ravinia Consulting, Inc.
 Ravinia Consulting, Inc. Ravinia Consulting, Inc. is a company located in the US. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
